等待开盘 09-16 09:30:00 美东时间
-5.300
-2.33%
今日重点评级关注:富国银行:维持Pyxis Oncology"超配"评级,目标价从12美元升至19美元;Oppenheimer:维持Opus Genetics"跑赢大市"评级,目标价从10美元升至20美元
09-10 15:00
Piper Sandler analyst Dimple Gosai initiates coverage on MasTec (NYSE:MTZ) with a Overweight rating and announces Price Target of $321.
09-10 01:04
MasTec (NYSE:MTZ) has outperformed the market over the past 15 years by 4.55% on an annualized basis producing an average annual return of 17.91%. Currently, MasTec has a market capitalization of $19.26 billion. Buying $1000 In MTZ: If an investor had bought $1000 of MTZ stock 15 years ago, it would...
09-01 07:46
意法半导体上升3.33%;Pershing Square上升2.87%;莱纳建筑-B上升2.51%
08-15 06:10
今日重点评级关注:Canaccord Genuity:维持Sagimet Biosciences"买入"评级,目标价从49美元升至56美元;韦德布什:维持Zura Bio"跑赢大市"评级,目标价从15美元升至22美元
08-13 11:44
Goldman Sachs analyst Ati Modak maintains MasTec (NYSE:MTZ) with a Buy and lowers the price target from $508 to $409.
08-13 02:16
MasTec (NYSE:MTZ) has outperformed the market over the past 20 years by 8.17% on an annualized basis producing an average annual return of 17.48%. Currently, MasTec has a market capitalization of $22.41 billion. Buying $100 In MTZ: If an investor had bought $100 of MTZ stock 20 years ago, it would b...
08-12 23:00
MasTec ( ($MTZ) ) has shared an update. On August 6, 2026, MasTec, Inc. priced ...
08-11 06:25
今日重点评级关注:HC Wainwright & Co.:维持Enlivex"买入"评级,目标价从20美元升至80美元;Canaccord Genuity:维持Pharming Group NV Sponsored ADR"买入"评级,目标价从37美元升至38美元
08-04 11:45